Machine learning-based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results.
Journal Information
Full Title: Cancer Med
Abbreviation: Cancer Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"CONFLICT OF INTEREST STATEMENT There are no conflicts of interest of the authors."
Funding Disclosure
Evidence found in paper:
"FUNDING INFORMATION Zhejiang Provincial Medical and Health Science and Technology Plan Project (2022KY669 and 2022KY1058); Hangzhou Health Science and Technology Plan Project (B20220443)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025